Deccan Healthcar Stock Price Today (NSE: 542248)
Fundamental Score
Deccan Healthcar Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Deccan Healthcar share price today is ₹13.08, down 0.91% on NSE/BSE as of 7 August 2026. Deccan Healthcar (542248) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹32.17 (Cr). The 52-week high for 542248 share price is ₹21.20 and the 52-week low is ₹6.65. At a P/E ratio of 12.92x, 542248 is currently trading below its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 2.30% and a debt-to-equity ratio of 0.04.
Deccan Healthcar Share Price Chart — NSE/BSE Historical Performance
Deccan Healthcar share price chart: -4.13% return over the past month. 52-week high ₹21.20, 52-week low ₹6.65.
Deccan Healthcar — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹13.69 | ₹13.69 | ₹12.60 | ₹13.08 | 834.00 (Cr) | |
| ₹13.80 | ₹13.80 | ₹12.85 | ₹13.20 | 7.80K (Cr) | |
| ₹13.00 | ₹13.48 | ₹12.50 | ₹13.39 | 10.12K (Cr) | |
| ₹13.02 | ₹13.30 | ₹13.00 | ₹13.00 | 1.12K (Cr) | |
| ₹12.78 | ₹13.15 | ₹12.20 | ₹13.10 | 9.66K (Cr) | |
| ₹13.45 | ₹13.45 | ₹12.41 | ₹12.53 | 13.93K (Cr) | |
| ₹12.60 | ₹13.07 | ₹12.60 | ₹13.06 | 7.49K (Cr) | |
| ₹13.08 | ₹13.14 | ₹12.44 | ₹12.66 | 3.57K (Cr) | |
| ₹13.08 | ₹13.08 | ₹12.96 | ₹13.08 | 12.57K (Cr) | |
| ₹12.65 | ₹12.99 | ₹12.17 | ₹12.46 | 4.15K (Cr) |
Deccan Healthcar — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹13.02 | ₹13.80 | ₹12.50 | ₹13.08 | +0.46% | |
| ₹13.70 | ₹13.80 | ₹12.02 | ₹13.10 | -4.38% | |
| ₹13.15 | ₹13.75 | ₹11.80 | ₹13.07 | -0.61% | |
| ₹13.07 | ₹13.75 | ₹11.58 | ₹12.85 | -1.68% | |
| ₹6.85 | ₹12.81 | ₹6.85 | ₹12.81 | +87.01% | |
| ₹13.60 | ₹13.89 | ₹6.65 | ₹6.85 | -49.63% | |
| ₹14.48 | ₹16.00 | ₹13.05 | ₹13.52 | -6.63% | |
| ₹15.45 | ₹15.99 | ₹13.00 | ₹13.54 | -12.36% | |
| ₹15.89 | ₹17.00 | ₹13.00 | ₹14.81 | -6.80% | |
| ₹18.40 | ₹18.40 | ₹15.20 | ₹16.00 | -13.04% | |
| ₹19.93 | ₹20.00 | ₹14.50 | ₹17.95 | -9.93% | |
| ₹20.00 | ₹21.20 | ₹18.55 | ₹19.24 | -3.80% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Deccan Healthcar Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Deccan Healthcar Fundamental Analysis & Valuation Benchmarking
Educational evaluation of 542248 across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Attractive Valuation (P/E: 12.92 vs Industry: 42.23)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (175.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (19.38% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (32.30% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (44.89% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.04)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (9.84x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (2.30%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.28%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Negative Free Cash Flow (₹-32.43 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (19.46%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 5.68%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Deccan Healthcar vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Deccan Healthcar with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
45.1/100 | ₹13.08₹13 | ₹32.17₹32.17 | 12.92Average 12.9 Average | 2.30%Poor 2.30% Poor | 3.28%Poor 3.28% Poor | 0.04Excellent 0.0 Excellent | 44.89%Excellent 44.89% Excellent | 19.38%Excellent 19.38% Excellent | 0.00% | |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 57.7/100 | ₹1905.20₹1905 | ₹28908.91₹28908.91 | 55.39Average 55.4 Average | 22.30%Excellent 22.30% Excellent | 28.00%Excellent 28.00% Excellent | 0.08Excellent 0.1 Excellent | 12.33%Good 12.33% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1344.40₹1344 | ₹14307.85₹14307.85 | 82.71Average 82.7 Average | 19.74%Good 19.74% Good | 21.29%Excellent 21.29% Excellent | 0.44Excellent 0.4 Excellent | 15.47%Excellent 15.47% Excellent | 16.66%Excellent 16.66% Excellent | 0.14% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹582.45₹582 | ₹11858.49₹11858.49 | 60.38Average 60.4 Average | 13.81%Average 13.81% Average | 17.77%Good 17.77% Good | 0.15Excellent 0.1 Excellent | 1.46%Average 1.46% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹579.00₹579 | ₹8420.27₹8420.27 | 52.36Average 52.4 Average | 28.40%Excellent 28.40% Excellent | 35.38%Excellent 35.38% Excellent | 0.09Excellent 0.1 Excellent | 8.37%Good 8.37% Good | 10.88%Good 10.88% Good | 1.76% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹527.45₹527 | ₹1777.47₹1777.47 | 17.31Average 17.3 Average | 10.89%Average 10.89% Average | 12.70%Average 12.70% Average | 0.54Good 0.5 Good | -11.13%Poor -11.13% Poor | 11.75%Good 11.75% Good | 0.50% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 56.2/100 | ₹252.15₹252 | ₹1359.30₹1359.30 | 42.23Average 42.2 Average | 14.12%Average 14.12% Average | 16.97%Good 16.97% Good | 0.53Good 0.5 Good | 31.68%Excellent 31.68% Excellent | 17.26%Excellent 17.26% Excellent | 0.00% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹564.95₹565 | ₹1178.25₹1178.25 | 16.95Average 16.9 Average | 65.27%Excellent 65.27% Excellent | 87.02%Excellent 87.02% Excellent | 0.00Excellent 0.0 Excellent | 97.21%Excellent 97.21% Excellent | 167.02%Excellent 167.02% Excellent | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 60.3/100 | ₹1248.10₹1248 | ₹1079.13₹1079.13 | 18.42Average 18.4 Average | 19.77%Good 19.77% Good | 25.48%Excellent 25.48% Excellent | 0.01Excellent 0.0 Excellent | -12.44%Poor -12.44% Poor | -8.95%Poor -8.95% Poor | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹239.10₹239 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price28908.91 Cr
- Vijaya Diagnostic Centre Ltd share price14307.85 Cr
- Metropolis Healthcare Ltd share price11858.49 Cr
- Thyrocare Technologies Ltd share price8420.27 Cr
- Krsnaa Diagnostics Ltd share price1777.47 Cr
Deccan Healthcar Quarterly Performance
Latest quarterly metrics for 542248 — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
1.11%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
175.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
19.38%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
44.89%
Compounded annual net profit growth over 5 years
Deccan Healthcar Technical Indicators
SMA 50, SMA 200, RSI and volume signals for 542248 — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Deccan Healthcar Financial Statements
Annual income statement, balance sheet and cash flow for Deccan Healthcar (542248) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Deccan Healthcar
About 542248 (Deccan Healthcar)
Deccan Healthcar (542248) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider sector wi...th a current market capitalisation of ₹32.17 (Cr). Deccan Healthcar has delivered a Return on Equity (ROE) of 2.30% and a ROCE of 3.28%. The debt-to-equity ratio stands at 0.04, reflecting the company's capital structure. Investors tracking 542248 share price can monitor key metrics including P/E ratio, promoter holding of 19.46%, and quarterly earnings growth.
Company Details
542248 Share Price: Frequently Asked Questions
What is the current share price of Deccan Healthcar?
Deccan Healthcar (542248) trades at ₹13.08 on BSE. Market cap ₹32.17 (Cr). Educational data only.
What is the P/E ratio of Deccan Healthcar?
Deccan Healthcar has a P/E of 12.92x vs industry average 42.23x.
What is the Bull Run score for Deccan Healthcar?
Deccan Healthcar has a Bull Run score of 45.1/100 based on 25+ financial parameters.
Does Deccan Healthcar pay dividends?
Deccan Healthcar has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Deccan Healthcar?
Deccan Healthcar has ROE of 2.30%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Deccan Healthcar?
Deccan Healthcar has debt-to-equity of 0.04.
Is Deccan Healthcar a good investment?
Bull Run gives Deccan Healthcar a score of 45.1/100. This is not investment advice — consult a SEBI-registered advisor.